Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative vs Postoperative XELOX in Advanced Gastric Adenocarcinoma (repeat)
NCT01665274Phase 2Terminated
- Sponsor
- Harbin Medical University
- Start
- Sep 2013
- Primary completion
- Aug 2020
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, oxaliplatin in gastric adenocarcinoma, sponsored by Harbin Medical University. Started Sep 2013; status: terminated.
02
Drugs
capecitabineoxaliplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT01665274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01665274.